The transmembrane receptor CD40 and its ligand (CD40L or CD154) are involved in initiating and sustaining the inflammatory response. While these responses are beneficial in infection and tumour lysis, chronic activation has been implicated in a range of neuroinflammatory and autoimmune conditions, including MS, Alzheimer’s disease and Parkinson’s disease. Read More
Neurology
ECTRIMS-ACTRIMS 2023 HIGHLIGHTS – FRIDAY, OCTOBER 13 EDITION
October 13, 20239th Joint ECTRIMS-ACTRIMS meeting – 11-13 October 2023
The following summarizes some of the highlights from Day 3 of ECTRIMS-ACTRIMS 2023.
ECTRIMS-ACTRIMS 2023 HIGHLIGHTS – THURSDAY, OCTOBER 12 EDITION
October 12, 20239th Joint ECTRIMS-ACTRIMS meeting – 11-13 October 2023
The following summarizes some of the highlights from Day 2 of ECTRIMS-ACTRIMS 2023.
ECTRIMS-ACTRIMS 2023 HIGHLIGHTS – WEDNESDAY, OCTOBER 11 EDITION
October 11, 20239th Joint ECTRIMS-ACTRIMS meeting – 11-13 October 2023
The following summarizes some of the highlights from Day 1 of ECTRIMS-ACTRIMS 2023.
EYE TRACKING AS A BIOMARKER OF MS SEVERITY (NEUROSOUND PODCAST)
October 3, 2023Click here to listen to the podcast
A McGill University study has examined the potential usefulness of tracking eye movements as a biomarker of physical and cognitive dysfunction in patients with multiple sclerosis (de Villers-Sidani et al. Front Neurol 2023;14:1243594). Read More